World Tuberculosis Day 2015

The TB situation in 2013: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office for Europe

ECDC TB TeamEuropean Centre for Disease Prevention and Control

Stockholm, 24 March 2015

TB notifications by country

In 2013, 64 844 TB cases were reported in the EU/EEA.The notification rate was 12.7 per 100 000 population (range 3.4–83.5).

2

Figure 1: TB notification rate per 100 000 population by country, EU/EEA, 2013

Not included or not reporting

20 to 49 per 100 000

10 to 19 per 100 000

5 to 9 per 100 000

< 5 per 100 000

≥ 50 per 100 000

TB notification rate over time

The TB notification rate has decreased from 19.3 per 100 000 population in 2004 to 12.7 in 2013.

3

Figure 2: TB notification rate per 100 000 population in EU/EEA 2004−2013

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

case

s/100 0

00

Year of reporting

EU definition: confirmed TB cases*

4

Figure 3: Percentage of laboratory-confirmed TB cases by country, EU/EEA, 2013

70 to 79%

≥ 80%

60 to 69%

< 60%

Not included or not reporting

* Confirmed by culture or by both a positive sputum microscopy result and Mycobacterium tuberculosis nucleic acid identified in nucleic acid amplification test.

In 2013, 62.1% (range 21.4–94.3%) of TB cases reported in the EU/EEA were laboratory confirmed.

Previously treated TB cases

5

In 2013, the proportion of all previously treated TB cases in the EU/EEA was 11.7% (range 0.0–23.0%).

Figure 4: Percentage of previously treated TB cases by country, EU/EEA, 2013

Not included or not reporting

10 to 14.9%

≥ 15%

5 to 9.9%

< 5%

TB in children

6

Figure 5: TB notification rate in children under 15 years of age per 100 000 child population, by country, EU/EEA, 2013

Not included or not reporting

4 to 9.9 per 100 000 child population

2 to 3.9 per 100 000 child population

≥ 10 per 100 000 child population

< 2 per 100 000 child population

In 2013, 2 655 TB cases in children were reported, accounting for 4.1% of all notified TB cases (range 0–9.5%) in the EU/EEA.

TB cases of foreign origin

7

In 2013, the proportion of TB cases of foreign origin in the EU/EEA was 28.0% (range 0.3–94.7%).

Figure 6: Percentage of TB cases of foreign origin by country, EU/EEA, 2013

25 to 49.9%

≥ 75%

1 to 24.9%

50 to 74.9%

< 1%

Not included or not reporting

TB cases of foreign origin over time

The percentage of foreign TB cases increased from 18.2% in 2004 to 28.0% in 2013. The notification rate of foreign-origin TB cases has remained stable since 2004 (between 3.4 and 3.8 per 100 000 population).

8

Figure 7: Percentage of TB cases with foreign origin, EU/EEA, 2004−2013

0

5

10

15

20

25

30

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Perc

enta

ge

Year of reporting

Extrapulmonary TB cases

9

In 2013, the proportion of extrapulmonary TB cases in the EU/EEA was 22.3% (range 4.7–63.6%).

Figure 8: Percentage of extrapulmonary TB cases by country, EU/EEA, 2013

20 to 29.9%

≥ 40%

10 to 19.9%

30 to 39.9%

< 10%

Not included or not reporting

Multidrug-resistant TB among all TB cases

10

In 2013, the proportion of TB cases with multidrug-resistance in the EU/EEA was 4.1% (range 0–22.7%).

Figure 9: Percentage of MDR TB among all confirmed TB cases by country, EU/EEA, 2013

2 to 4.9%

≥ 10%

1 to 1.9%

5 to 9.9%

< 1%

Not included or not reporting

Multidrug-resistant TB case notification rate over time

The rate of notified MDR TB cases has remained stable over the past five years at 0.3 per 100 000 population.

11

Figure 10: MDR TB notification rate per 100 000 population in EU/EEA 2009−2013

0.0

0.1

0.2

0.3

0.4

0.5

2009 2010 2011 2012 2013

case

s/100 0

00

Year of reporting

Multidrug-resistance among new pulmonary TB cases

12

Figure 11: Percentage of new pulmonary TB cases with MDR TB by country, EU/EEA, 2013

2 to 4.9%

1 to 1.9%

≥ 5%

< 1%

Not reporting

In 2013, the percentage of new pulmonary TB cases with multidrug-resistance in the EU/EEA was 2.6% (range 0–17.3%).

Multidrug-resistance among previously treated pulmonary TB cases

13

In 2013, the proportion of previously treated pulmonary TB cases with multidrug-resistance in the EU/EEA was 17.0% (range 0–100.0%).

Figure 12: Percentage of previously treated pulmonary TB cases with MDR TB by country, EU/EEA, 2013

10 to 19.9%

≥ 20%

1 to 9.9%

< 1%

Not reporting

Extensively drug-resistant TB (XDR TB)

14

In 2013, the proportion of extensively drug-resistant TB cases among multidrug-resistant cases in the EU/EEA was 17.5% (range 0–100.0% and 4.2–36.4% for countries reporting more than one case).

Figure 13: Percentage of XDR TB cases among MDR TB cases tested for second-line drug susceptibility, by country, EU/EEA, 2013

20 to 29.9%

10 to 19.9%

≥30%

< 10%

Not reporting

TB/HIV co-infection

15

In 2013, the proportion HIV positive among TB cases with known HIV status in EU/EEA was 4.9% (range 0–22.6%).

Figure 14: Percentage of HIV-positive cases among TB cases with known HIV status, by country, EU/EEA, 2013

5 to 9.9%

1 to 4.9%

≥10%

< 1%

Not reporting

Treatment success after 12 months in all TB cases*

The treatment success rate for all TB cases notified in 2012 was 73.5% (range: 10.3–87.8%) and has remained stable over the past five years.

16

Figure 15: Treatment success rate of TB cases notified in 2012, by country, EU/EEA, 2013

* Four EU/EEA Member States did not report treatment outcome data

0 20 40 60 80 100

EU/EEA

Croatia

Malta

Cyprus

Finland

Estonia

Ireland

Poland

Denmark

Austria

Lithuania

Hungary

Spain

Germany

Czech Republic

Belgium

Portugal

Latvia

Norway

United Kingdom

Romania

Sweden

Slovenia

Iceland

Netherlands

Bulgaria

Slovakia

Treatment success (%)

Treatment success in new confirmed pulmonary TB cases and relapses started on treatment in 2012*The treatment success rate for confirmed new pulmonary TB cases and relapses notified in 2012 was 77.1% (range: 9.3–90.0%).

17

Figure 16: Treatment success rate in confirmed new pulmonary TB cases and relapses started on treatment in 2012, by country, EU/EEA, 2013

* Cases started on second line treatment are excluded

0 20 40 60 80 100

EU/EEA

Croatia

Malta

Cyprus

Finland

Poland

Ireland

Denmark

Spain

Hungary

Austria

Germany

Portugal

Czech Republic

Belgium

Norway

United Kingdom

Estonia

Sweden

Romania

Netherlands

Slovenia

Bulgaria

Latvia

Slovakia

Iceland

Treatment success (%)

Treatment success rate in multidrug-resistant TB*

The treatment success rate for all multidrug-resistant TB cases notified in 2011 was 37.8% (range 0–75.0%).

18

Figure 17: 24-month treatment success rate in multidrug-resistant TB cases notified in 2011, by country, EU/EEA, 2013

* Malta and Slovenia reported zero MDR TB cases in 2011, 9 Member States did not report treatment outcome data for MDR TB cases

0 20 40 60 80

EU/EEA

Denmark

Romania

Czech Republic

Ireland

Slovakia

Poland

Lithuania

Hungary

United Kingdom

Estonia

Portugal

Germany

Latvia

Bulgaria

Netherlands

Austria

Sweden

Belgium

Norway

Treatment success (%)

Treatment outcome in multidrug-resistant TB over time

The treatment outcomes for multidrug-resistant TB cases improved slightly between the 2009 and 2011 cohort, EU/EEA.

19

Figure 18: 24-month treatment outcome in multidrug-resistant TB cases notified from 2009 to 2011, by year of initial case reporting, EU/EEA

0

10

20

30

40

Success Died Failed Defaulted orunknown

Still on treatment

Tre

atm

ent

outc

om

e (

%)

MDR TB cohort 2009 MDR TB cohort 2010 MDR TB cohort 2011

20

Treatment success in extensively drug-resistant TB*

The treatment success rate in extensively drug-resistant TB cases notified in 2010 was 25.9% (range 0–100.0%).

20

Figure 19: 36-month treatment success rate in extensively drug-resistant TB cases notified in 2010, by country, EU/EEA, 2013

* Cyprus, Denmark, Italy, Norway, Slovakia and Slovenia reported zero XDR TB cases in 2010, 12 countries did not report SLD DST results or XDR TB treatment outcome data

0

20

40

60

80

100

Tre

atm

ent

succ

ess

(%

)